From: Portal vein thrombosis; risk factors, clinical presentation and treatment
Analysis | Patients with cancer or cirrhosis N = 19 | Patients without cancer and cirrhosis N = 48 | ||||
---|---|---|---|---|---|---|
Presentation | Presentation | |||||
Acute | Chronic | N (% of total) | Acute | Chronic | N (% of total) | |
Portal hypertensive gastropathy | 4 (40%) | 3 (33%) | 7 (37%) | 5 (29%) | 16 (52%) | 21 (44%) |
Gastric varices | 4 (40%) | 4 (44%) | 8 (42%) | 4 (24%) | 16 (52%) | 20 (42%) |
Oesophageal varices, small | 4 (40%) | 6 (67%) | 10 (53%) | 7 (41%) | 18 (58%) | 25 (52%) |
Oesophageal varices, large | 1 (10%) | 1 (11%) | 2 (11%) | 1 (6%) | 10 (32%) | 1 (23%) |
Haemorrhages (1–2) | 2 (20%) | 4 (44%) | 6 (32%) | 0 | 10 (32%) | 10 (21%) |
Haemorrhages (repeated) | 3 (30%) | 1 (11%) | 4 (21%) | 0 | 4 (13%) | 4 (8%) |
Ascites | 4 (40%) | 4 (44%) | 8 (42%) | 8 (47%) | 12 (39%) | 20 (42%) |
Total | 10 (53%) | 9 (47%) | 19 (100%) | 17 (35%) | 31 (65%) | 51 (100%) |